HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor-infiltrating lymphocytes and dendritic cells in human colorectal cancer: their relationship to KRAS mutational status and disease recurrence.

Abstract
The prognosis of newly diagnosed colorectal cancer patients relies mostly on tumor-node metastasis classification. However, analyses of tumor-infiltrating lymphocytes and several molecular markers have also shown promising prognostic value. Mutations in the proto-oncogene KRAS, which occur early in colorectal carcinogenesis, have been demonstrated to be common in human colorectal cancer (CRC); however, their prognostic significance remains controversial. We examined the correlations between KRAS mutational status and tumor-infiltrating immune cells with respect to CRC recurrence. Mutations in KRAS were identified in 45.5% of the primary carcinomas in our cohort of patients: 65% in codon 12 and 35% in codon 13. Although codon 13 KRAS mutations were associated with disease relapse, they were present in both disease-free and relapsed patients. However, disease-free and relapsed patients differed markedly in their patterns of tumor-infiltrating immune cells. There was a trend toward decreased density of tumor-infiltrating lymphocytes (TILs) within the group of relapsed cases. In addition, relapsed patients with codon 13 mutations had markedly lower levels of tumor-infiltrating mature DC-LAMP(+) dendritic cells (DCs) and higher frequency of CD1a(+) cells compared with disease-free patients. Our data suggest that CRC patients with low levels of TILs, a high CD1a(+)/DC-LAMP(+) tumor-infiltrating DC ratio, and a KRAS mutation in codon 13 are at a high risk of disease recurrence.
AuthorsPetr Kocián, Monika Šedivcová, Jan Drgáč, Kateřina Cerná, Jiří Hoch, Roman Kodet, Jiřina Bartůňková, Radek Špíšek, Anna Fialová
JournalHuman immunology (Hum Immunol) Vol. 72 Issue 11 Pg. 1022-8 (Nov 2011) ISSN: 1879-1166 [Electronic] United States
PMID21884745 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antigens, CD1
  • Biomarkers, Tumor
  • CD1a antigen
  • Cell Adhesion Molecules, Neuronal
  • GPI-Linked Proteins
  • KRAS protein, human
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • limbic system-associated membrane protein
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins
Topics
  • Antigens, CD1 (biosynthesis)
  • Biomarkers, Tumor (genetics)
  • Carcinoma (diagnosis, genetics, pathology, physiopathology)
  • Cell Adhesion Molecules, Neuronal (biosynthesis)
  • Cell Differentiation (genetics)
  • Cell Movement (genetics)
  • Colorectal Neoplasms (diagnosis, genetics, pathology, physiopathology)
  • DNA Mutational Analysis
  • Dendritic Cells (immunology, metabolism, pathology)
  • Early Detection of Cancer
  • Female
  • Follow-Up Studies
  • GPI-Linked Proteins (biosynthesis)
  • Genetic Association Studies
  • Humans
  • Lymphocytes, Tumor-Infiltrating (immunology, metabolism, pathology)
  • Male
  • Mutation (genetics)
  • Neoplasm Recurrence, Local
  • Prognosis
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins (genetics)
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: